Keytruda IV infusion 100mg, manufactured by MSD, contains Pembrolizumab (genetical recombination), a PD-1 blocking antibody. It is an immunotherapy medication used to treat various cancers, including melanoma, non-small cell lung cancer, and head and neck cancer. This 100mg 4mL bottle has a YJ code of 4291435A2025.
Keytruda IV infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →